Know Cancer

forgot password

Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas

18 Years
Open (Enrolling)
Astrocytoma, Oligodendroglioma, Oligoastrocytoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Glioblastoma, Brain Tumors, Brain Cancer

Thank you

Trial Information

Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas

Inclusion Criteria

Inclusion/Exclusion Criteria:

- 18 years of age

- Brain tumor(s) to be resected for clinical reasons.

- Histological pathology confirmation that tumor is of glial origin, WHO Grade II, III
or IV.

- Adequate tissue available for processing as determined by Pathology.

- Adequate decision making ability to review, discuss and sign a consent form to allow
their tumor samples to be used for future human brain tumor biology laboratory
research. Determination of capacity to consent is made by one of the co-investigators
based on clinical assessment.

- Patients opting for the standard treatment regimen for their disease as well as
ongoing clinical trials will be are eligible to participate in this study. Standard
care for newly-diagnosed glioblastomas typically consists of surgical resection
followed by radiotherapy with concomitant temozolomide, followed by adjuvant
temozolomide chemotherapy.

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Overall Survival

Outcome Description:

Patients will be followed for survival every 12 weeks +/- 1 week.

Outcome Time Frame:

24 months

Safety Issue:


Principal Investigator

Arti B Gaur, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dartmouth-Hitchcock Medical Center


United States: Institutional Review Board

Study ID:




Start Date:

May 2013

Completion Date:

December 2015

Related Keywords:

  • Astrocytoma
  • Oligodendroglioma
  • Oligoastrocytoma
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Brain Tumors
  • Brain Cancer
  • glioblastoma
  • miRNA
  • GBM
  • astrocytoma
  • Astrocytoma
  • Brain Neoplasms
  • Glioblastoma
  • Oligodendroglioma



Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire  03756